Zealand Pharma
Clinical trials sponsored by Zealand Pharma, explained in plain language.
-
Weekly shot shows promise for shedding pounds in obesity trial
Disease control CompletedThis study tested a new medicine called petrelintide, given once a week, to help people with obesity or overweight (plus related health problems like high blood pressure) lose weight. About 493 adults took part, receiving either different doses of petrelintide or a placebo, along…
Phase: PHASE2 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
New obesity drug petrelintide put to the test in early study
Knowledge-focused CompletedThis completed Phase 1 study tested a single injection of petrelintide, a drug being developed for weight management, in 48 adults with a BMI of 27 or higher. The goal was to see if different concentrations of the same dose change how the body absorbs and processes the drug, and …
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated May 26, 2026 10:17 UTC
-
Kidney function may change how Weight-Loss drug works
Knowledge-focused CompletedThis study looked at how the weight-management drug petrelintide behaves in people with different levels of kidney function. Researchers compared 39 adults with normal kidneys to those with mild, moderate, or severe kidney impairment. The goal was to see if kidney problems change…
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated May 26, 2026 10:15 UTC